Anesthesia Induction, Hemodynamic Stability, Transcatheter Aortic Valve Replacement
Conditions
Brief summary
The purpose of this study is to evaluate whether the administration of 5 ml/kg of colloid solution prior to anesthesia induction, compared with 5 ml/kg of lactated Ringer's solution, can reduce hemodynamic fluctuations during the induction period (defined as the first 15 minutes after induction) in patients undergoing Transcatheter Aortic Valve Replacement (TAVR).
Interventions
5 ml/kg of hydroxyethyl starch 130/0.4 electrolyte injection is administered by infusion pump over 15 minutes before anesthesia induction.
5 ml/kg of sodium lactate Ringer's solution is administered before anesthesia induction.
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 years; * Patients scheduled to undergo elective TAVR under general anesthesia;
Exclusion criteria
* Allergy to hydroxyethyl starch, its components, and/or sodium lactate Ringer's solution, or a history of colloidal allergy; * Severe cardiac dysfunction (ejection fraction\[EF\] \< 35%); * Severe renal dysfunction (creatinine \> 132 μg/L and/or requiring renal replacement therapy); * Morbid obesity (body mass index\[BMI\] \> 37.5 kg/m² or \> 32.5 kg/m² with metabolic diseases); * Severe hepatic dysfunction ; * Severe electrolyte disturbances ; * Patients with preoperative intracranial hypertension requiring dehydration therapy; * Expected postoperative hospital stay \< 24 hours; * Patients scheduled for multiple surgeries during this hospitalization.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The area under curve (AUC) of the change in mean arterial pressure from baseline during the induction period. | induction period, at an average of 15 minutes | The AUC below baseline MAP is calculated as: ∑ (((Si - Sbaseline)+(Si-1 - Sbaseline))/2 × ΔX) where Sbaseline is the baseline MAP, Si is the MAP at minute i (i = 0.5, 1, 1.5…15), and ΔX is the time interval between measurements. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of post-induction hemodynamic instability, defined as arterial pressure (MAP)< 65 mmHg or a decrease of more than 20% from baseline within 15 minutes after induction. | 15 minutes after induction | — |
| Intraoperative use of vasoactive drugs. | Intraoperative period, at an average of 2 hours | — |
| Sequential Organ Failure Assessment(SOFA )score on the first postoperative day | The first postoperative day, at 24 hours after surgery | SOFA score grades organ dysfunction from 0 (normal) to 4 (most abnormal) for six organ systems . The total score is the sum of all six sub-scores, ranging from 0 to 24 . The higher score means the worse organ function. |
| Length of hospital stay. | The duration of the patient's hospitalization after the initial surgery, at an average of 5 days. | — |
| Proportion of patients admitted to the intensive care unit (ICU) after surgery | During the postoperative period prior to discharge (at an average of 5 days) | — |
| In-hospital all-cause mortality | During the postoperative period prior to discharge (at an average of 5 days) | — |
| All-cause mortality within 30 days postoperatively | 30 days after surgery | — |
| Proportion of patients receiving renal replacement therapy during the 30-day postoperative observation period | 30 days after surgery | — |
Contacts
Air Force Medical University